A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor

Structure

Volumn 16, Issue 6, 2008, Pages 897-905

  Hanson, Michael A ^a   Cherezov, Vadim ^a   Griffith, Mark T ^a   Roth, Christopher B ^a   Jaakola, Veli Pekka ^a   Chien, Ellen Y T ^a   Velasquez, Jeffrey ^a   Kuhn, Peter ^a   Stevens, Raymond C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

PROTEINS

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; MONOMER; TIMOLOL;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CRYSTAL STRUCTURE; HUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN STRUCTURE; THERMOSTABILITY;

BINDING SITES; CHOLESTEROL; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ADRENERGIC, BETA-2; TEMPERATURE; TIMOLOL;

EUKARYOTA;

EID: 44649172481     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2008.05.001     Document Type: Article

References (38)

1. Alexandrov A.I., Mileni M., Chien E.Y.T., Hanson M.A., and Stevens R.C. Microscale fluorescent thermal stability assay for membrane proteins. Structure 16 (2008) 351-359
2. Baker J.G., Hall I.P., and Hill S.J. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol. Pharmacol. 64 (2003) 1357-1369
3. Ballesteros J.A., and Weinstein H. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. Methods Neurosci. 25 (1995) 366-428
4. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57 (2000) 1577-1592
5. Cherezov V., Peddi A., Muthusubramaniam L., Zheng Y.F., and Caffrey M. A robotic system for crystallizing membrane and soluble proteins in lipidic mesophases. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 1795-1807
6. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
7. Chidiac P., Hebert T.E., Valiquette M., Dennis M., and Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45 (1994) 490-499
8. DeDecker B.S., O'Brien R., Fleming P.J., Geiger J.H., Jackson S.P., and Sigler P.B. The crystal structure of a hyperthermophilic archaeal TATA-box binding protein. J. Mol. Biol. 264 (1996) 1072-1084
9. Eilers M., Shekar S.C., Shieh T., Smith S.O., and Fleming P.J. Internal packing of helical membrane proteins. Proc. Natl. Acad. Sci. USA 97 (2000) 5796-5801
10. Eilers M., Patel A.B., Liu W., and Smith S.O. Comparison of helix interactions in membrane and soluble α-bundle proteins. Biophys. J. 82 (2002) 2720-2736
11. Epand R.M., Sayer B.G., and Epand R.F. Caveolin scaffolding region and cholesterol-rich domains in membranes. J. Mol. Biol. 345 (2005) 339-350
12. Epand R.F., Thomas A., Brasseur R., Vishwanathan S.A., Hunter E., and Epand R.M. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45 (2006) 6105-6114
13. Gimpl G., and Fahrenholz F. Cholesterol as stabilizer of the oxytocin receptor. Biochim. Biophys. Acta 1564 (2002) 384-392
14. Gimpl G., Burger K., and Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 36 (1997) 10959-10974
15. Grossfield A., Feller S.E., and Pitman M.C. A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc. Natl. Acad. Sci. USA 103 (2006) 4888-4893
16. Hannawacker A., Krasel C., and Lohse M.J. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the β(2)-adrenergic receptor. Mol. Pharmacol. 62 (2002) 1431-1437
17. Jamin N., Neumann J.M., Ostuni M.A., Vu T.K., Yao Z.X., Murail S., Robert J.C., Giatzakis C., Papadopoulos V., and Lacapere J.J. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19 (2005) 588-594
18. Lee A.G. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666 (2004) 62-87
19. Li H., and Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139 (1998) 4991-4997
20. Marheineke K., Grunewald S., Christie W., and Reilander H. Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett. 441 (1998) 49-52
21. Milligan G., Svoboda P., and Brown C.M. Why are there so many adrenoceptor subtypes?. Biochem. Pharmacol. 48 (1994) 1059-1071
22. Niu S.L., Mitchell D.C., and Litman B.J. Manipulation of cholesterol levels in rod disk membranes by methyl-β-cyclodextrin: effects on receptor activation. J. Biol. Chem. 277 (2002) 20139-20145
23. Ostrom R.S., Gregorian C., Drenan R.M., Xiang Y., Regan J.W., and Insel P.A. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J. Biol. Chem. 276 (2001) 42063-42069
24. Pang L., Graziano M., and Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry 38 (1999) 12003-12011
25. Pattabiraman N., Ward K.B., and Fleming P.J. Occluded molecular surface: analysis of protein packing. J. Mol. Recognit. 8 (1995) 334-344
26. Pucadyil T.J., and Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim. Biophys. Acta 1663 (2004) 188-200
27. Pucadyil T.J., and Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45 (2006) 295-333
28. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
29. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Yao X.J., Weis W.I., Stevens R.C., et al. GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318 (2007) 1266-1273
30. Roth C.B., Hanson M.A., and Stevens R.C. Stabilization of the human β2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure. J. Mol. Biol. 376 (2008) 1305-1319
31. Rybin V.O., Xu X., Lisanti M.P., and Steinberg S.F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. J. Biol. Chem. 275 (2000) 41447-41457
32. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
33. Steinberg S.F. β2-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts. J. Mol. Cell. Cardiol. 37 (2004) 407-415
34. Takeda S., Kadowaki S., Haga T., Takaesu H., and Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520 (2002) 97-101
35. Wieland K., Zuurmond H.M., Krasel C., Ijzerman A.P., and Lohse M.J. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the β2-adrenergic receptor. Proc. Natl. Acad. Sci. USA 93 (1996) 9276-9281
36. Xiang Y., and Kobilka B. The PDZ-binding motif of the β2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc. Natl. Acad. Sci. USA 100 (2003) 10776-10781
37. Yao Z., and Kobilka B. Using synthetic lipids to stabilize purified β2 adrenoceptor in detergent micelles. Anal. Biochem. 343 (2005) 344-346
38. Zimmerman T.J., and Kaufman H.E. Timolol. A β-adrenergic blocking agent for the treatment of glaucoma. Arch. Ophthalmol. 95 (1977) 601-604